EIF4EBP1 Protein (4E-BP1)

EIF4EBP1 Protein (4E-BP1)

Pathway Diagram

```mermaid
flowchart TD
EIF4EBP1["EIF4EBP1<br/>Translation Repressor"]
MTOR["MTOR<br/>Mechanistic Target<br/>of Rapamycin"]
MTOR_pathway["mTOR Signaling<br/>Pathway"]
Autophagy["Autophagy<br/>Pathway"]
MAP1LC3B["MAP1LC3B (LC3)<br/>Autophagosome<br/>Marker"]
LAMP1["LAMP1<br/>Lysosomal<br/>Membrane"]
Lysosomal_deg["Lysosomal<br/>Degradation"]
PPARGC1A["PPARGC1A<br/>Metabolic<br/>Coactivator"]
Lipid_metabolism["Lipid Metabolism<br/>Pathway"]
RPS6["RPS6<br/>Ribosomal<br/>Protein S6"]
MYC["MYC<br/>Transcription<br/>Factor"]
ALS["Amyotrophic<br/>Lateral Sclerosis"]
MS["Multiple<br/>Sclerosis"]
Ischemia["Cerebral<br/>Ischemia"]
Metabolic_syndrome["Metabolic<br/>Syndrome"]

MTOR -->|"phosphorylates/inhibits"| EIF4EBP1
EIF4EBP1 -->|"regulates"| MTOR_pathway
EIF4EBP1 -->|"regulates"| Autophagy
EIF4EBP1 -->|"regulates"| MAP1LC3B
EIF4EBP1 -->|"regulates"| LAMP1
EIF4EBP1 -->|"activates"| Lysosomal_deg
EIF4EBP1 -->|"regulates"| PPARGC1A
EIF4EBP1 -->|"activates"| Lipid_metabolism
EIF4EBP1 -->|"regulates"| RPS6
EIF4EBP1 -->|"regulates"| MYC
EIF4EBP1 -->|"interacts with"| ALS
EIF4EBP1 -->|"regulates"| MS
EIF4EBP1 -->|"regulates"| Ischemia
EIF4EBP1 -->|"activates"| Metabolic_syndrome

EIF4EBP1 Protein (4E-BP1)

Pathway Diagram

Overview

4E-Binding Protein 1 (4E-BP1, encoded by EIF4EBP1) is a translational repressor that plays a central role in regulating protein synthesis via the [mTOR](/mechanisms/mtor-signaling-pathway) signaling pathway. It is a key downstream effector of mTORC1 and has been implicated in various neurodegenerative diseases through its effects on synaptic plasticity, protein homeostasis, and neuronal survival. [@ebp2020]

<div class="infobox infobox-protein"> [@mtor2019]
<div class="infobox-header">4E-BP1 (EIF4EBP1)</div> [@mtorebp2021]
<table> [@translational2022]
<tr><th>Gene</th><td>[EIF4EBP1](/genes/eif4ebp1)</td></tr> [@ebp2021]
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprot/Q13541" target="_blank">Q13541</a></td></tr> [@mtor2020]
<tr><th>PDB ID</th><td><a href="https://www.ebi.ac.uk/pdbe/5TGK" target="_blank">5TGK</a>, <a href="https://www.ebi.ac.uk/pdbe/6G3L" target="_blank">6G3L</a></td></tr> [@translational2019]
<tr><th>Protein Family</th><td>eIF4E-binding protein family</td></tr>
<tr><th>Molecular Weight</th><td>~12 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm, Nucleus</td></tr>
<tr><th>Expression</th><td>Ubiquitous; high in brain</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">180 edges</a></td>
</tr>
</table>
</div>

Structure

4E-BP1 is a small, natively unfolded protein with the following features:

• eIF4E-binding motif (YXXXXLΦ): Located in N-terminal region (residues 54-67)
• Phosphorylation sites: Multiple serine/threonine residues (T37, T46, S65, T70)
• C-terminal region: Less structured, involved in protein interactions
• RRM-like domain: Predicted RNA-binding capability

Normal Function

In the normal nervous system, 4E-BP1 regulates:

Role in Neurodegeneration

Alzheimer's Disease

In AD, 4E-BP1 dysregulation contributes to:

• Impaired synaptic translation: Reduced synaptic protein synthesis [1]
• mTOR hyperactivation: Common in AD brain, leading to 4E-BP1 hyperphosphorylation [2]
• [Tau](/proteins/tau) pathology: mTOR/4E-BP1 pathway promotes tau phosphorylation [3]
• Memory deficits: Translational dysregulation underlies cognitive decline [4]

Parkinson's Disease

In PD:

• Dysregulated mTOR signaling in dopaminergic [neurons](/entities/neurons)
• Contributes to [alpha-synuclein](/proteins/alpha-synuclein) translation control
• Involved in mitochondrial protein homeostasis
• May affect LRRK2 pathology [5]

Amyotrophic Lateral SALS

In ALS:

• Altered translational control in motor neurons
• Associated with [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology
• mTOR dysregulation contributes to proteostasis failure
• May affect stress granule dynamics [6]

Huntington's Disease

In HD:

• Mutant [huntingtin](/proteins/huntingtin) affects mTOR/4E-BP1 signaling
• Translational dysregulation in striatal neurons
• Contributes to synaptic protein loss
• Linked to cognitive decline [7]

Therapeutic Targeting

Strategies

• mTOR inhibitors (rapamycin, everolimus): Indirectly activate 4E-BP1
• eIF4E-4E-BP1 interaction disruptors: Novel therapeutic approach
• Translation modulators: Target cap-dependent translation

Clinical Status

• mTOR inhibitors in clinical trials for AD
• Rapamycin being tested for neurodegenerative diseases
• Gene therapy approaches in development

Protein Interactions

| Partner | Interaction Type | Function |
|---------|------------------|----------|
| eIF4E | Binding | Translation initiation inhibition |
| mTORC1 | Regulation | Phosphorylation |
| PRAS40 | Binding | mTORC1 substrate |
| RICTOR | Interaction | mTORC2 regulation |
| PP1 | Dephosphorylation | Activity regulation |

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References